TempraMed Technologies (HAM:9DY) Beginning Cash Position: €0.19 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:9DY TempraMed Technologies Ltd HAM:9DY
7 GF Score
Price €0.19
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies Beginning Cash Position?

TempraMed Technologies HAM:9DY -3.12% 7 Beginning Cash Position is €0.19 Mil as of Jun. 2026. GuruFocus rates HAM:9DY with a GF Score™ of 7/100. The stock has 5 warning signs investors should review.

TempraMed Technologies's Beginning Cash Position for the quarter that ended in Jun. 2026 was €0.19 Mil.

TempraMed Technologies's quarterly Beginning Cash Position declined from Dec. 2025 (€2.13 Mil) to Mar. 2026 (€0.82 Mil) and declined from Mar. 2026 (€0.82 Mil) to Jun. 2026 (€0.19 Mil).

TempraMed Technologies's annual Beginning Cash Position increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.05 Mil) but then declined from Dec. 2024 (€0.05 Mil) to Dec. 2025 (€0.02 Mil).

TempraMed Technologies Beginning Cash Position Related Terms

TempraMed Technologies Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies Beginning Cash Position Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
Beginning Cash Position
0.00 0.05 0.02

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.03 2.13 0.82 0.19
HAM:9DY
7GF Score
TempraMed Technologies Ltd HAM:9DY
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €0.19 Mil mean?
TempraMed Technologies (HAM:9DY) has a Beginning Cash Position of €0.19 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on TempraMed Technologies and its competitors.
Is TempraMed Technologies' Beginning Cash Position too high?
TempraMed Technologies' current Beginning Cash Position is €0.19 Mil. Overall, TempraMed Technologies has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Beginning Cash Position compare to ABT and SYK?
TempraMed Technologies' Beginning Cash Position of €0.19 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current Beginning Cash Position is €0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (HAM:9DY) has a current Beginning Cash Position of €0.19 Mil. The current Beginning Cash Position is €0.19 Mil. TempraMed Technologies' overall GF Score™ is 7/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For TempraMed Technologies (HAM:9DY), the current Beginning Cash Position is €0.19 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
7GF Score

Get the complete analysis for HAM:9DY

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price